Brief: Royalty Pharma Announces $1 Bln Share Repurchase Program
27/03/2023 12:34
March 27 (Reuters) - Royalty Pharma PLC RPRX.O :
* ROYALTY PHARMA ANNOUNCES $1.0 BILLION SHARE REPURCHASE
PROGRAM
* ROYALTY PHARMA SAYS ADDITIONALLY, PABLO LEGORRETA, CEO,
INDICATED TO PURCHASE UP TO $50 MILLION OF COMPANY'S CLASS A
ORDINARY SHARES
Source text for Eikon: ID:nGNXbpl3Nl
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)